The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?

<p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological an...

Full description

Bibliographic Details
Main Authors: S. A. Budagaev, A. V. Afanasyev, A. V. Bogachev-Prokophiev, A. S. Zalesov, M. A. Ovcharov
Format: Article
Language:Russian
Published: Meshalkin National Medical Research Center 2021-06-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012
id doaj-ada2f2b10f2641bfab3a9625d79b88f6
record_format Article
spelling doaj-ada2f2b10f2641bfab3a9625d79b88f62021-06-30T03:06:12Zrus Meshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192021-06-0125210811510.21688/1681-3472-2021-2-108-1151361The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?S. A. Budagaev0A. V. Afanasyev1A. V. Bogachev-Prokophiev2A. S. Zalesov3M. A. Ovcharov4Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, НовосибирскФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск<p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological and invasive methods of treating symptomatic patients with obstruction of the left ventricular outlet. Considering the most recent clinical studies, the indications for invasive methods of treatment have expanded to include septal myectomy and alcohol septal ablation. A separate section in the guidelines has been devoted to the management of non-obstructive hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. The recommendations for patients with hypertrophic cardiomyopathy with atrial fibrillation, ventricular arrhythmias and severe heart failure have been revised.</p><p>Received 26 March 2021. Revised 12 May 2021. Accepted 13 May 2021.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Conception and study design: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev<br />Data collection and analysis: S.A. Budagaev, M.A. Ovcharov<br />Drafting the article: S.A. Budagaev, A.V. Afanasyev, A.S. Zalesov<br />Critical revision of the article: A.V. Bogachev-Prokophiev<br />Final approval of the version to be published: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev, A.S. Zalesov, <br />M.A. Ovcharov</p>http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012гипертрофическая кардио­мио­патияклинические рекомендации
collection DOAJ
language Russian
format Article
sources DOAJ
author S. A. Budagaev
A. V. Afanasyev
A. V. Bogachev-Prokophiev
A. S. Zalesov
M. A. Ovcharov
spellingShingle S. A. Budagaev
A. V. Afanasyev
A. V. Bogachev-Prokophiev
A. S. Zalesov
M. A. Ovcharov
The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
Патология кровообращения и кардиохирургия
гипертрофическая кардио­мио­патия
клинические рекомендации
author_facet S. A. Budagaev
A. V. Afanasyev
A. V. Bogachev-Prokophiev
A. S. Zalesov
M. A. Ovcharov
author_sort S. A. Budagaev
title The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
title_short The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
title_full The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
title_fullStr The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
title_full_unstemmed The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?
title_sort 2020 american heart association / american college of cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: what is new?
publisher Meshalkin National Medical Research Center
series Патология кровообращения и кардиохирургия
issn 1681-3472
2500-3119
publishDate 2021-06-01
description <p>On 22 December 2020, <em>Circulation</em> published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological and invasive methods of treating symptomatic patients with obstruction of the left ventricular outlet. Considering the most recent clinical studies, the indications for invasive methods of treatment have expanded to include septal myectomy and alcohol septal ablation. A separate section in the guidelines has been devoted to the management of non-obstructive hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. The recommendations for patients with hypertrophic cardiomyopathy with atrial fibrillation, ventricular arrhythmias and severe heart failure have been revised.</p><p>Received 26 March 2021. Revised 12 May 2021. Accepted 13 May 2021.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Conception and study design: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev<br />Data collection and analysis: S.A. Budagaev, M.A. Ovcharov<br />Drafting the article: S.A. Budagaev, A.V. Afanasyev, A.S. Zalesov<br />Critical revision of the article: A.V. Bogachev-Prokophiev<br />Final approval of the version to be published: S.A. Budagaev, A.V. Afanasyev, A.V. Bogachev-Prokophiev, A.S. Zalesov, <br />M.A. Ovcharov</p>
topic гипертрофическая кардио­мио­патия
клинические рекомендации
url http://journalmeshalkin.ru/index.php/heartjournal/article/view/1012
work_keys_str_mv AT sabudagaev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT avafanasyev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT avbogachevprokophiev the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT aszalesov the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT maovcharov the2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT sabudagaev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT avafanasyev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT avbogachevprokophiev 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT aszalesov 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
AT maovcharov 2020americanheartassociationamericancollegeofcardiologyguidelinesforthediagnosisandtreatmentofpatientswithhypertrophiccardiomyopathywhatisnew
_version_ 1721353657677512704